The Walgreens share price is up 30% in 2021. Should I buy?

The Walgreens share price is having a good run. But will this continue. Here I take a closer look at the pharmacy giant.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

The Walgreens Boots Alliance (NASDAQ: WBA) share price has jumped over 30% since the beginning of the year. The stock is also up 30% during the past 12 months. But on a five-year view, the shares are down 30%.

So is now a buying opportunity? I’m not convinced it is. Clearly the Walgreens share price has seen a recent uptick. But I think there are problems the company needs to sort out before I dip my toe in.

Walgreens: an overview

Walgreens is a global retailer and pharmaceuticals firm. It’s known for dispensing and distributing medicines through its retail stores and digital platforms, as well as for selling cosmetics products. 

It operates Walgreens and Duane Reade shops in the US. In Europe and Asia, the pharmacy giant runs Boots stores. In terms of international wholesale and distribution networks, it works under the Alliance Healthcare banner.

It also has global health and beauty brands. These include No7, Soap & Glory, Liz Earle, Botanics, Sleek MakeUP and YourGoodSkin.

Bull case

I think one of the reasons why the Walgreens share price has been rising is due to the pandemic. The company is conducting Covid-19 tests and vaccinations at its stores, especially in the US.

This increase in footfall should help drive sales. But also the general recovery should act as a tailwind too. Higher pharmacy footfall should get customers through the doors of to buy its other products.

Walgreens’ shops also sell snacks and beverages as well as its own health and beauty brands. These products carry higher margins, which should benefit from the increase in footfall.

The company is accelerating its move to digital having recognised that it has trailed its competitors. It’s currently ramping up the use of technology across its business. In fact, despite the Boots chain having struggled, in Q2, its e-commerce business saw sales doubling and Boots gained beauty market share.

In its second quarter results, the company indicated that it’s on track to deliver in excess of $2bn in annual cost savings by the 2022 financial year. If this is executed, it should boost profitability.

Bear case

I’m concerned that the firm is facing fierce competition. The pharmaceutical industry is being disrupted. Healthcare is becoming digital and there are many companies that are pushing into the sector.

Even Amazon is dipping its toe in the market, which could impact the Walgreens share price. I don’t think this online threat is going away any time soon and it could hinder the company’s growth prospects.

My other concern is that the pharmacy giant does not have a good track record when it comes to profitability. Margins have been decreasing over the years. And it does not help that there is a large amount of debt on the balance sheet too.

So if margins are weak and it’s paying a dividend, I’m unsure how it will make a dent in its debt pile from excess cash flow. Also there is no guarantee that the pick-up in sales due to the coronavirus crisis will continue after the pandemic.

For now, I’ll monitor the Walgreen share price. But I reckon there is still a lot of work the company needs to do.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Nadia Yaqub has no position in any of the shares mentioned. John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool UK owns shares of and has recommended Amazon and recommends the following options: long January 2022 $1920 calls on Amazon and short January 2022 $1940 calls on Amazon. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Analysts have upgraded this FTSE 100 stock to Buy. What should investors do?

Associated British Foods shares have been uninspiring for some time. But is it finally time to consider buying the FTSE…

Read more »

Man changing battery on electric bicycle
Investing Articles

Prediction: in 12 months the sizzling National Grid share price could turn £10,000 into…

It's been another solid year for the National Grid share price and the dividend yield is decent too. So why…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Up 185% in 3 years, why does the market love this FTSE 250 stock

Over the past three years, this stock has vastly outperformed the FTSE 250. Dr James Fox takes a closer look…

Read more »

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Investing Articles

Looking for growth, dividends, or value? These 3 ETFs could be smart ideas to consider

Exchange-traded funds (ETFs) provide a way for investors to spread risk without sacrificing the possibility of huge long-term returns.

Read more »

Happy couple showing relief at news
Investing Articles

Is the Rolls-Royce share price fast becoming a joke?

The FTSE 100 engineering titan has done brilliantly in recent years. But our writer wonders whether the Rolls-Royce share price…

Read more »

Middle-aged white male courier delivering boxes to young black lady
Investing Articles

Is there a ‘best age’ to start buying shares?

Christopher Ruane weighs some possible pros and cons of waiting to start buying shares for the first time, versus starting…

Read more »

piggy bank, searching with binoculars
Investing Articles

Is it time to look again at the FTSE 250’s worst performers?

Our writer considers the prospects for two of the worst-performing shares on the FTSE 250, with falls of at least…

Read more »

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Investing For Beginners

Down over 40% in the past year, I think investors should consider these value shares

Jon Smith points out two value shares that have fallen heavily over the past year but are starting to look…

Read more »